日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Population Pharmacokinetics of Z-Endoxifen in Patients With Advanced Solid Tumors

晚期实体瘤患者中Z-恩多昔芬的群体药代动力学

Koubek, Emily J; Ralya, Andrew T; Larson, Thomas R; McGovern, Renee M; Buhrow, Sarah A; Covey, Joseph M; Adjei, Alex A; Takebe, Naoko; Ames, Matthew M; Goetz, Matthew P; Reid, Joel M

Phase 1 trial of ontuxizumab (MORAb-004) in children with relapsed or refractory solid tumors: A report from the Children's Oncology Group Phase 1 Pilot Consortium (ADVL1213)

ontuxizumab (MORAb-004) 治疗复发或难治性实体瘤儿童的 1 期试验:儿童肿瘤协作组 1 期试点联盟 (ADVL1213) 的报告

Norris, Robin E; Fox, Elizabeth; Reid, Joel M; Ralya, Andrew; Liu, Xiaowei W; Minard, Charles; Weigel, Brenda J

First-in-Human Phase I Study of the Tamoxifen Metabolite Z-Endoxifen in Women With Endocrine-Refractory Metastatic Breast Cancer

首次人体I期研究:他莫昔芬代谢物Z-恩多昔芬治疗内分泌难治性转移性乳腺癌女性患者

Goetz, Matthew P; Suman, Vera J; Reid, Joel M; Northfelt, Don W; Mahr, Michael A; Ralya, Andrew T; Kuffel, Mary; Buhrow, Sarah A; Safgren, Stephanie L; McGovern, Renee M; Black, John; Dockter, Travis; Haddad, Tufia; Erlichman, Charles; Adjei, Alex A; Visscher, Dan; Chalmers, Zachary R; Frampton, Garrett; Kipp, Benjamin R; Liu, Minetta C; Hawse, John R; Doroshow, James H; Collins, Jerry M; Streicher, Howard; Ames, Matthew M; Ingle, James N

Acute estrogen surge enhances inflammatory nociception without altering spinal Fos expression

急性雌激素激增增强炎症痛觉而不改变脊髓 Fos 表达

Andrew Ralya, Kenneth E McCarson